Article ID | Journal | Published Year | Pages | File Type |
---|---|---|---|---|
8691948 | World Neurosurgery | 2018 | 20 Pages |
Abstract
PFDD can be an optimal surgical strategy because of its higher clinical improvement and lower recurrence rate in the patients with syringomyelia. In patients without syringomyelia, PFD can be a preferred choice because of its similar clinical improvement and lower costs. Future randomized studies with large numbers and the power to provide illumination for surgical decision making in CM-1 are warranted.
Related Topics
Life Sciences
Neuroscience
Neurology
Authors
Weiwei Lin, Guman Duan, Jinjin Xie, Jiashen Shao, Zhaoqi Wang, Baohua Jiao,